News
07-09-2008, 01:06 AM
The U.S. Food and Drug Administration on Tuesday approvedInvitrogen Corp's genetic test for determining whether patientswith breast cancer are good candidates for treatment with the drugHerceptin.
More... (http://www.healthcentral.com/breast-cancer/news-256001-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-256001-66.html)